OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
What Is the Most Suitable Agent Combined With Apatinib for Transarterial Chemoembolization Treatment in Advanced Hepatocellular Carcinoma Patients? A Systematic Review and Network Meta-analysis
Fuhai Hui, Chang Xu, Xiangbo Xu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Fuhai Hui, Chang Xu, Xiangbo Xu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Showing 8 citing articles:
Efficacy and Safety of Lenvatinib Combined With PD-1 Inhibitors Plus TACE for Unresectable Hepatocellular Carcinoma Patients in China Real-World
Xiaowei Li, Zhigang Fu, Xiaoxia Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 28
Xiaowei Li, Zhigang Fu, Xiaoxia Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 28
The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis
Yingshi Zhang, Xiangbo Xu, Kaisi Yang, et al.
European Journal of Pharmacology (2024) Vol. 983, pp. 176952-176952
Closed Access | Times Cited: 2
Yingshi Zhang, Xiangbo Xu, Kaisi Yang, et al.
European Journal of Pharmacology (2024) Vol. 983, pp. 176952-176952
Closed Access | Times Cited: 2
Diagnostic accuracy and prognostic significance of Glypican-3 in hepatocellular carcinoma: A systematic review and meta-analysis
Donglei Jiang, Yingshi Zhang, Yinuo Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Donglei Jiang, Yingshi Zhang, Yinuo Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Efficacy and safety of apatinib and transcatheter arterial chemoembolization as second-line therapy for advanced hepatocellular carcinoma: A retrospective cohort study
Tao Li, Jingfang Zhao, Shuai Zhang, et al.
Journal of Cancer Research and Therapeutics (2023) Vol. 19, Iss. 1, pp. 57-63
Open Access | Times Cited: 4
Tao Li, Jingfang Zhao, Shuai Zhang, et al.
Journal of Cancer Research and Therapeutics (2023) Vol. 19, Iss. 1, pp. 57-63
Open Access | Times Cited: 4
Incidence of renal cell carcinoma after solid organ transplantation: a systematic review and meta-analysis
Chang Xu, Hefeng Geng, Yannan Li, et al.
BMC Urology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Chang Xu, Hefeng Geng, Yannan Li, et al.
BMC Urology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Nrf2-siRNA Enhanced the Anti-Tumor Effects of As2O3 in 5-Fluorouracil-Resistant Hepatocellular Carcinoma by Inhibiting HIF-1α/HSP70 Signaling
Xuhua Duan, Wenze Xu, Hao Li, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 1341-1352
Open Access | Times Cited: 6
Xuhua Duan, Wenze Xu, Hao Li, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 1341-1352
Open Access | Times Cited: 6
DHW-208, A Novel Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Has Anti-Hepatocellular Carcinoma Activity Through Promoting Apoptosis and Inhibiting Angiogenesis
Shu Wang, Yuting Wu, Mingyue Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Shu Wang, Yuting Wu, Mingyue Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Incidence of Renal Cell Carcinoma after Solid Organ Transplantation: a Systematic Review and Meta-analysis
Yang Wang, Yannan Li, Hefeng Geng, et al.
Research Square (Research Square) (2023)
Open Access
Yang Wang, Yannan Li, Hefeng Geng, et al.
Research Square (Research Square) (2023)
Open Access
